213 related articles for article (PubMed ID: 34144042)
1. Evaluation of the application of TSH receptor stimulating autoantibodies and the optimization of detection strategy in Graves' disease.
Tong M; Ding J; Huang B; Chen J; Wei X; Li Z; Shu J; Hu Z; Jiang X; Sheng H
Clin Chim Acta; 2021 Oct; 521():34-39. PubMed ID: 34144042
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism.
Liu T; Zhang X; Long L; Zhou L; Chen J; Li M; Gao Y; Zhou X; Han X; Ji L
BMC Endocr Disord; 2022 Aug; 22(1):218. PubMed ID: 36045442
[TBL] [Abstract][Full Text] [Related]
3. Clinical diagnostic performance of a fully automated TSI immunoassay vs. that of an automated anti‑TSHR immunoassay for Graves' disease: a Chinese multicenter study.
Cheng X; Chai X; Ma C; Jia Q; Zhao H; Dong Z; Zhang Z; Hu Y; Song A; Yang G; Qiu L; Lian X
Endocrine; 2021 Jan; 71(1):139-148. PubMed ID: 32562184
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the first fully automated immunoassay method for the measurement of stimulating TSH receptor autoantibodies in Graves' disease.
Tozzoli R; D'Aurizio F; Villalta D; Giovanella L
Clin Chem Lab Med; 2017 Jan; 55(1):58-64. PubMed ID: 27331310
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the diagnostic performance of thyroid-stimulating immunoglobulin and thyrotropin receptor antibodies for Graves' disease.
Xu S; Shao W; Wu Q; Zhu J; Pan B; Wang B; Guo W
J Clin Lab Anal; 2023 Apr; 37(8):e24890. PubMed ID: 37161617
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease.
Stan MN; Algeciras-Schimnich A; Murthy V; Thapa P; Araki N
Thyroid; 2022 Feb; 32(2):170-176. PubMed ID: 34714163
[No Abstract] [Full Text] [Related]
8. Clinical efficacy of thyroid-stimulating immunoglobulin detection for diagnosing Graves' disease and predictors of responsiveness to methimazole.
Liu K; Fu Y; Li T; Liu S; Chen D; Zhao C; Shi Y; Cai Y; Yang T; Zheng X
Clin Biochem; 2021 Nov; 97():34-40. PubMed ID: 34331946
[TBL] [Abstract][Full Text] [Related]
9. Performance of Thyroid-Stimulating Immunoglobulin Bioassay and Thyrotropin-Binding Inhibitory Immunoglobulin Assay for the Diagnosis of Graves' Disease in Patients With Active Thyrotoxicosis.
Silva de Morais N; Angell TE; Ahmadi S; Alexander EK; Dos Santos Teixeira PF; Marqusee E
Endocr Pract; 2022 May; 28(5):502-508. PubMed ID: 35091101
[TBL] [Abstract][Full Text] [Related]
10. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
11. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays.
Pedersen IB; Knudsen N; Perrild H; Ovesen L; Laurberg P
Clin Endocrinol (Oxf); 2001 Sep; 55(3):381-90. PubMed ID: 11589682
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial.
Schott M; Hermsen D; Broecker-Preuss M; Casati M; Mas JC; Eckstein A; Gassner D; Golla R; Graeber C; van Helden J; Inomata K; Jarausch J; Kratzsch J; Miyazaki N; Moreno MA; Murakami T; Roth HJ; Stock W; Noh JY; Scherbaum WA; Mann K
Clin Endocrinol (Oxf); 2009 Oct; 71(4):566-73. PubMed ID: 19170704
[TBL] [Abstract][Full Text] [Related]
13. Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves' Orbitopathy.
Khamisi S; Lundqvist M; Engström BE; Larsson A; Karlsson FA; Ljunggren Ö
Exp Clin Endocrinol Diabetes; 2023 Apr; 131(4):236-241. PubMed ID: 36706788
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a coated-tube assay for antithyrotropin receptor antibodies in patients with Graves' disease and other thyroid disorders.
Cardia MS; Lima N; Knobel M; Medeiros-Neto G
Thyroid; 2004 Apr; 14(4):295-300. PubMed ID: 15142363
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
Giovanella L; Ceriani L; Garancini S
Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
[TBL] [Abstract][Full Text] [Related]
16. Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.
Woo YJ; Jang SY; Lim TH; Yoon JS
Korean J Ophthalmol; 2015 Aug; 29(4):213-9. PubMed ID: 26240504
[TBL] [Abstract][Full Text] [Related]
17. Measurement of anti-TSH receptor antibodies: what is the correct cut-off value?
Smit MA; van Kinschot CMJ; van der Linden J; van Noord C; Kos S
Neth J Med; 2020 Mar; 78(2):55-63. PubMed ID: 32332174
[TBL] [Abstract][Full Text] [Related]
18. TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis.
Tozzoli R; Bagnasco M; Giavarina D; Bizzaro N
Autoimmun Rev; 2012 Dec; 12(2):107-13. PubMed ID: 22776786
[TBL] [Abstract][Full Text] [Related]
19. Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases.
Liu C; Hermsen D; Domberg J; Graeber C; Hautzel H; Duan Y; Xu KF; Liu CP; Mao XD; Cupisti K; Scherbaum WA; Schott M
Horm Metab Res; 2008 Jul; 40(7):479-83. PubMed ID: 18504673
[TBL] [Abstract][Full Text] [Related]
20. Relevance of TSH-receptor antibody levels in predicting disease course in Graves' orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay.
Jang SY; Shin DY; Lee EJ; Lee SY; Yoon JS
Eye (Lond); 2013 Aug; 27(8):964-71. PubMed ID: 23743527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
